Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

NCT02430714 · clinicaltrials.gov ↗

COMPLETED

Status

629

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: Lenvatinib

Sponsor

Eisai Co., Ltd.